HitGen has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.  In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall. Under the terms of the agreement, HitGen will receive upfront payments, and be eligible for milestone payments from Almirall. Specific financial details were not disclosed. “We are delighted ...